LEP and metabolic dysfunction-associated steatotic liver disease: Based on our findings, it is reasonable to believe that leptin levels may be used for the assessment of NAFLD, including the screening of people who are traditionally at high risk of developing NAFLD (e.g., those with comorbid diabetes and those who are overweight), and, more importantly, for the assessment of the risk of developing lean NAFLD in people with normal BMI.